Compass Therapeutics, Inc. (CMPX) has 20 tenedores institucionales e internos conocidos registrados. El mayor tenedor es ORBIMED ADVISORS LLC con 15,219,994 acciones. Otros tenedores destacados incluyen OrbiMed Genesis GP LLC y Schuetz Thomas J..
En los últimos 12 meses, los internos han realizado 18 transacciones en CMPX acciones — 13 compras (valoradas en $25.24M) y 0 ventas (valoradas en RSU Award). Las compras internas han superado las ventas durante este período, lo que puede señalar confianza en las perspectivas de la empresa.
CMPX Participación de Insiders
Principal Titular
ORBIMED ADVISORS LLC
15,219,994 acciones
Compras (12 meses)
13
$25.24M valor
Ventas (12 meses)
0
$0.00 valor
Actividad de Transacciones (12 meses)
Principales Titulares Internos
| # |
Nombre |
Cargo |
Acciones en Propiedad |
Última Declaración |
Tamaño Relativo |
| 1 |
Orbimed Advisors Llc |
Director |
15,219,994 |
2022-11-10 |
|
| 2 |
Orbimed Genesis Gp Llc |
Director |
14,690,178 |
2022-05-13 |
|
| 3 |
Schuetz Thomas J. |
Chief Executive Officer |
6,603,336 |
2026-02-10 |
|
| 4 |
Tompkins Mark N. |
10 Percent Owner |
4,750,000 |
2018-07-30 |
|
| 5 |
Bisker-leib Vered |
Chief Executive Officer |
3,124,426 |
2024-02-09 |
|
| 6 |
Sunderland Julie |
Director |
2,212,907 |
2020-06-23 |
|
| 7 |
Sirard Cynthia |
Chief Medical Officer |
1,000,000 |
2026-01-05 |
|
| 8 |
Prasad Arjun |
Chief Commercial Officer |
1,000,000 |
2026-01-05 |
|
| 9 |
Shin Barry |
CFO |
525,000 |
2026-01-05 |
|
| 10 |
Anderson Errik |
10 Percent Owner |
383,642 |
2020-06-29 |
|
| 11 |
Lerner Neil |
Chief Accounting Officer |
382,500 |
2026-01-05 |
|
| 12 |
Jacobs Ian Seth |
President, Sec, CEO, & CFO |
250,000 |
2018-07-30 |
|
| 13 |
Anderman Jonathan |
General Counsel |
171,000 |
2026-01-05 |
|
| 14 |
Ferneau Philip |
Director |
90,000 |
2026-01-05 |
|
| 15 |
Lindahl Richard S |
Director |
90,000 |
2026-01-05 |
|
| 16 |
Gordon Carl L |
Director |
90,000 |
2026-01-05 |
|
| 17 |
Chiniara Ellen |
Director |
90,000 |
2026-01-05 |
|
| 18 |
Boylan James P |
Director |
90,000 |
2026-01-05 |
|
| 19 |
Gray Mary Ann |
Director |
90,000 |
2026-01-05 |
|
| 20 |
Kalled Susan |
Chief Scientific Officer |
60,000 |
2022-02-23 |
|
Transacciones Recientes (últimos 12 meses)
| Fecha |
Nombre |
Cargo |
Tipo |
Acciones |
Precio |
Valor |
| 2026-02-08 |
Schuetz Thomas J. |
Chief Executive Officer |
Retención Fiscal de RSU |
36,687 |
$6.52 |
$239.2K |
| 2026-01-09 |
Schuetz Thomas J. |
Chief Executive Officer |
Retención Fiscal de RSU |
46,777 |
$5.35 |
$250.26K |
| 2026-01-02 |
Prasad Arjun |
Chief Commercial Officer |
Concesión de RSU |
1,000,000 |
$5.17 |
$5.17M |
| 2026-01-02 |
Prasad Arjun |
Officer |
Desconocido |
- |
- |
- |
| 2026-01-02 |
Anderman Jonathan |
General Counsel |
Concesión de RSU |
150,000 |
$5.17 |
$775.5K |
| 2026-01-02 |
Boylan James P |
Director |
Concesión de RSU |
90,000 |
$5.17 |
$465.3K |
| 2026-01-02 |
Ferneau Philip |
Director |
Concesión de RSU |
90,000 |
$5.17 |
$465.3K |
| 2026-01-02 |
Sirard Cynthia |
Chief Medical Officer |
Concesión de RSU |
1,000,000 |
$5.17 |
$5.17M |
| 2026-01-02 |
Sirard Cynthia |
Officer |
Desconocido |
- |
- |
- |
| 2026-01-02 |
Shin Barry |
CFO |
Concesión de RSU |
125,000 |
$5.17 |
$646.25K |
| 2026-01-02 |
Schuetz Thomas J. |
CEO |
Concesión de RSU |
2,000,000 |
$5.17 |
$10.34M |
| 2026-01-02 |
Lerner Neil |
Chief Accounting Officer |
Concesión de RSU |
62,500 |
$5.17 |
$323.13K |
| 2026-01-02 |
Chiniara Ellen |
Director |
Concesión de RSU |
90,000 |
$5.17 |
$465.3K |
| 2026-01-02 |
Gordon Carl L |
Director |
Concesión de RSU |
90,000 |
$5.17 |
$465.3K |
| 2026-01-02 |
Gray Mary Ann |
Director |
Concesión de RSU |
90,000 |
$5.17 |
$465.3K |
| 2026-01-02 |
Lindahl Richard S |
Director |
Concesión de RSU |
90,000 |
$5.17 |
$465.3K |
| 2025-11-16 |
Schuetz Thomas J. |
Chief Executive Officer |
Retención Fiscal de RSU |
44,025 |
$4.83 |
$212.64K |
| 2025-05-27 |
Schuetz Thomas J. |
Chief Executive Officer |
Compra Informativa |
10,000 |
$2.11 |
$21.1K |
